Conflicts of Interest — Editorialists Respond

To the Editor: We appreciate the opportunity to present our perspective on the events surrounding the publication in the Journal of our editorial “Pharmacotherapy for Obesity — Do the Benefits Outweigh the Risks?” (Aug. 29 issue). 1 We hope this letter will help clarify the genuine misunderstandings...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 335; no. 14; pp. 1064 - 1065
Main Authors Manson, JoAnn E, Faich, Gerald A
Format Journal Article
LanguageEnglish
Published United States Massachusetts Medical Society 03.10.1996
Subjects
Appetite Depressants - therapeutic use
Bioethics
Biomedical Research
Conflict of Interest
Disclosure
Editorial Policies
Fenfluramine - therapeutic use
Humans
Obesity - drug therapy
Periodicals as Topic
Publishing - standards
Risk Assessment
New England Journal of Medicine
Biomedical and Behavioral Research
Online AccessGet full text

Cover

More Information
Summary:To the Editor: We appreciate the opportunity to present our perspective on the events surrounding the publication in the Journal of our editorial “Pharmacotherapy for Obesity — Do the Benefits Outweigh the Risks?” (Aug. 29 issue). 1 We hope this letter will help clarify the genuine misunderstandings that occurred between us and the Journal editors. In June 1996, one of the editors of the Journal telephoned Dr. Manson to invite her to write an editorial to accompany an article on appetite suppressants and primary pulmonary hypertension. 2 The written editorial policy of the Journal asked that authors “not have ongoing financial associations . . .
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJM199610033351414